Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy.

A. Gumley, M. O'Grady, L. McNay, J. Reilly, K. Power, John David Norrie

    Research output: Contribution to journalArticle

    179 Citations (Scopus)

    Abstract

    Background. The paper describes a randomized controlled trial of targeting cognitive behavioural therapy (CBT) during prodromal or early signs of relapse in schizophrenia. We hypothesized that CBT would result in reduced admission and relapse, reduced positive and negative symptoms, and improved social functioning.

    Method. A total of 144 participants with schizophrenia or a related disorder were randomized to receive either treatment as usual (TAU) (N = 72) or CBT + TAU (N = 72). Participants were prospectively followed up between entry and 12 months.

    Results. At 12 months, 11 (15(.)3 %) participants in the CBT group were admitted to hospital compared to 19 (26(.)4 %) of the TAU group (hazard ratio = 0(.)53, P = 0(.)10, 95 % CI 0(.)25, 1(.)10). A total of 13 (18(.)1 %) participants in CBT relapsed compared to 25 (34(.)7 %) in TAU (hazard ratio = 0(.)47, P < 0(.)05, 95 % CI 0(.)24, 0(.)92). In addition, the CBT group showed significantly greater improvement in positive symptoms, negative symptoms, global psychopathology, performance of independent functions and prosocial activities.

    Conclusions. The study provides evidence for the feasibility and effectiveness for targeting CBT on the appearance of early signs of relapse in schizophrenia. The results are discussed in context of the study's methodological limitations.

    Original languageEnglish
    Pages (from-to)419-431
    Number of pages12
    JournalPsychological Medicine
    Volume33
    Issue number3
    DOIs
    Publication statusPublished - 2003

    Keywords

    • FOLLOW-UP
    • FAMILY INTERVENTION
    • PSYCHOTIC RELAPSE
    • PRODROMAL SIGNS
    • PERSISTENT SYMPTOMS
    • EXPRESSED EMOTION
    • COPING STRATEGIES
    • PERSONAL THERAPY
    • 3-YEAR TRIALS
    • ADJUSTMENT

    Cite this

    Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy. / Gumley, A.; O'Grady, M.; McNay, L.; Reilly, J.; Power, K.; Norrie, John David.

    In: Psychological Medicine, Vol. 33, No. 3, 2003, p. 419-431.

    Research output: Contribution to journalArticle

    Gumley, A. ; O'Grady, M. ; McNay, L. ; Reilly, J. ; Power, K. ; Norrie, John David. / Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy. In: Psychological Medicine. 2003 ; Vol. 33, No. 3. pp. 419-431.
    @article{691797c2130642d5a272f9f2e5a2a829,
    title = "Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy.",
    abstract = "Background. The paper describes a randomized controlled trial of targeting cognitive behavioural therapy (CBT) during prodromal or early signs of relapse in schizophrenia. We hypothesized that CBT would result in reduced admission and relapse, reduced positive and negative symptoms, and improved social functioning.Method. A total of 144 participants with schizophrenia or a related disorder were randomized to receive either treatment as usual (TAU) (N = 72) or CBT + TAU (N = 72). Participants were prospectively followed up between entry and 12 months.Results. At 12 months, 11 (15(.)3 {\%}) participants in the CBT group were admitted to hospital compared to 19 (26(.)4 {\%}) of the TAU group (hazard ratio = 0(.)53, P = 0(.)10, 95 {\%} CI 0(.)25, 1(.)10). A total of 13 (18(.)1 {\%}) participants in CBT relapsed compared to 25 (34(.)7 {\%}) in TAU (hazard ratio = 0(.)47, P < 0(.)05, 95 {\%} CI 0(.)24, 0(.)92). In addition, the CBT group showed significantly greater improvement in positive symptoms, negative symptoms, global psychopathology, performance of independent functions and prosocial activities.Conclusions. The study provides evidence for the feasibility and effectiveness for targeting CBT on the appearance of early signs of relapse in schizophrenia. The results are discussed in context of the study's methodological limitations.",
    keywords = "FOLLOW-UP, FAMILY INTERVENTION, PSYCHOTIC RELAPSE, PRODROMAL SIGNS, PERSISTENT SYMPTOMS, EXPRESSED EMOTION, COPING STRATEGIES, PERSONAL THERAPY, 3-YEAR TRIALS, ADJUSTMENT",
    author = "A. Gumley and M. O'Grady and L. McNay and J. Reilly and K. Power and Norrie, {John David}",
    year = "2003",
    doi = "10.1017/S0033291703007323",
    language = "English",
    volume = "33",
    pages = "419--431",
    journal = "Psychological Medicine",
    issn = "0033-2917",
    publisher = "Cambridge University Press",
    number = "3",

    }

    TY - JOUR

    T1 - Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy.

    AU - Gumley, A.

    AU - O'Grady, M.

    AU - McNay, L.

    AU - Reilly, J.

    AU - Power, K.

    AU - Norrie, John David

    PY - 2003

    Y1 - 2003

    N2 - Background. The paper describes a randomized controlled trial of targeting cognitive behavioural therapy (CBT) during prodromal or early signs of relapse in schizophrenia. We hypothesized that CBT would result in reduced admission and relapse, reduced positive and negative symptoms, and improved social functioning.Method. A total of 144 participants with schizophrenia or a related disorder were randomized to receive either treatment as usual (TAU) (N = 72) or CBT + TAU (N = 72). Participants were prospectively followed up between entry and 12 months.Results. At 12 months, 11 (15(.)3 %) participants in the CBT group were admitted to hospital compared to 19 (26(.)4 %) of the TAU group (hazard ratio = 0(.)53, P = 0(.)10, 95 % CI 0(.)25, 1(.)10). A total of 13 (18(.)1 %) participants in CBT relapsed compared to 25 (34(.)7 %) in TAU (hazard ratio = 0(.)47, P < 0(.)05, 95 % CI 0(.)24, 0(.)92). In addition, the CBT group showed significantly greater improvement in positive symptoms, negative symptoms, global psychopathology, performance of independent functions and prosocial activities.Conclusions. The study provides evidence for the feasibility and effectiveness for targeting CBT on the appearance of early signs of relapse in schizophrenia. The results are discussed in context of the study's methodological limitations.

    AB - Background. The paper describes a randomized controlled trial of targeting cognitive behavioural therapy (CBT) during prodromal or early signs of relapse in schizophrenia. We hypothesized that CBT would result in reduced admission and relapse, reduced positive and negative symptoms, and improved social functioning.Method. A total of 144 participants with schizophrenia or a related disorder were randomized to receive either treatment as usual (TAU) (N = 72) or CBT + TAU (N = 72). Participants were prospectively followed up between entry and 12 months.Results. At 12 months, 11 (15(.)3 %) participants in the CBT group were admitted to hospital compared to 19 (26(.)4 %) of the TAU group (hazard ratio = 0(.)53, P = 0(.)10, 95 % CI 0(.)25, 1(.)10). A total of 13 (18(.)1 %) participants in CBT relapsed compared to 25 (34(.)7 %) in TAU (hazard ratio = 0(.)47, P < 0(.)05, 95 % CI 0(.)24, 0(.)92). In addition, the CBT group showed significantly greater improvement in positive symptoms, negative symptoms, global psychopathology, performance of independent functions and prosocial activities.Conclusions. The study provides evidence for the feasibility and effectiveness for targeting CBT on the appearance of early signs of relapse in schizophrenia. The results are discussed in context of the study's methodological limitations.

    KW - FOLLOW-UP

    KW - FAMILY INTERVENTION

    KW - PSYCHOTIC RELAPSE

    KW - PRODROMAL SIGNS

    KW - PERSISTENT SYMPTOMS

    KW - EXPRESSED EMOTION

    KW - COPING STRATEGIES

    KW - PERSONAL THERAPY

    KW - 3-YEAR TRIALS

    KW - ADJUSTMENT

    U2 - 10.1017/S0033291703007323

    DO - 10.1017/S0033291703007323

    M3 - Article

    VL - 33

    SP - 419

    EP - 431

    JO - Psychological Medicine

    JF - Psychological Medicine

    SN - 0033-2917

    IS - 3

    ER -